Missouri Attorney General Catherine Hanaway has expanded her state’s legal challenge to block mail-order abortion pills after the FDA approved a new generic mifepristone, arguing the decision ignores safety concerns and strips protections that once required in-person medical checks. The case seeks to roll back policies that allowed widespread distribution without traditional safeguards and forces a national conversation about telehealth, patient safety, and federal oversight.
Catherine Hanaway announced the lawsuit targeting a recently approved generic version of mifepristone produced by Evita Solutions, saying the drug is being pushed into the market without basic medical safeguards. The filing argues the FDA’s Sept. 30 decision opened the door to mail-order programs that deliver these drugs nationwide, often without any in-person evaluation.
The complaint contends the drug’s risks are well-documented and getting clearer as research and real-world reports accumulate, and it argues manufacturers have leaned on loosened safety rules. Officials say those weakened standards were originally meant to catch dangerous conditions like ectopic pregnancies, which require hands-on exams to diagnose and cannot be safely managed by mail delivery alone.
“Mifepristone is sending women to the hospital with life-threatening complications, and yet drug companies continue pushing new versions of it into the market without basic medical safeguards,” Hanaway said. “Mail-order abortion drugs are dangerous when taken without in-person care, and Missouri will not stand by while manufacturers gamble with women’s lives.”
The case builds on a multi-state effort accusing the FDA of dismantling critical safety protections around mifepristone, and it calls out an informal national system that routes pills to patients through telehealth and delivery services. Federal law has long prohibited mailing abortion drugs, yet distributors and telehealth networks have constructed a delivery mechanism that reaches patients in every state while sidestepping traditional safeguards and follow-up care.
Missouri, joined by Kansas and Idaho, is asking a court to block the recent approval and to restore pre-2016 safety requirements that mandated in-person medical evaluations before pills could be dispensed. The states also want an order stopping manufacturers and distributors from mailing these drugs nationwide, arguing the current setup violates federal statutes designed to protect patient safety.
Hanaway pointed to the drug’s labeling that notes roughly 1 in 25 women who take chemical abortion drugs end up in the emergency room and that many suffer hemorrhaging, infection, or require surgery. “No caring physician would call mifepristone ‘as safe as Tylenol,’” she said. “That claim was always false. Women are ending up in emergency rooms, and manufacturers know it. If the FDA is reevaluating the brand-name drug’s safety, then it needs to stop rubber-stamping new mail-order generic versions before more women are hurt.”
Republican lawmakers in Washington have been pressing the FDA to tighten oversight, arguing agencies moved too quickly to relax guardrails and that partnerships between regulators and drugmakers need scrutiny. Sen. Josh Hawley urged the FDA to “follow the science to put back safety guardrails,” and Sen. Bill Cassidy said he and other Republican senators have demanded answers from the agency about its decision to approve the new generic, but have yet to receive satisfactory responses.
Evita Solutions did not immediately respond to requests for comment, and the lawsuit sets up a likely court fight that could determine whether the FDA’s more permissive approach survives judicial review. The outcome will have implications for how telehealth operates in reproductive care and whether states can compel a return to in-person evaluations to protect patients.
Darnell Thompkins is a conservative opinion writer from Atlanta, GA, known for his insightful commentary on politics, culture, and community issues. With a passion for championing traditional values and personal responsibility, Darnell brings a thoughtful Southern perspective to the national conversation. His writing aims to inspire meaningful dialogue and advocate for policies that strengthen families and empower individuals.